Chinese healthcare firms expand overseas to support expat communities

Chinese healthcare companies are expanding overseas to serve growing expatriate communities in the Middle East and Southeast Asia. Distinct Healthcare plans to open a clinic in Dubai this year, while Gushengtang eyes 50 centers in the region.

Chinese healthcare companies are venturing abroad to cater to expatriate communities in regions like the Middle East and Southeast Asia, where many mainland firms are establishing operations across sectors.

“A wide range of Chinese companies are expanding overseas,” setting up local operations and bringing Chinese employees with them, said Philip Wang, CEO of Distinct Healthcare Holdings, in an interview on Monday.

“Chinese expatriate workers are often not familiar with the local healthcare system,” said Wang. “If there is a Chinese-run clinic, they may come to us. We can help bridge the language gap … or we can help connect them with some local resources to assist them.”

He added that the company plans to follow the flow of Chinese customers into international markets.

The Shenzhen-based private healthcare service provider plans to open its first clinic in Dubai, the financial hub of the United Arab Emirates, this year, after making inroads earlier into Singapore and Kuala Lumpur, Malaysia.

Meanwhile, TCM group Gushengtang eyes 50 centres in Southeast Asia to serve Chinese communities there.

On Friday, Distinct Healthcare raised HK$284.53 million (US$36.4 million) from its initial public offering (IPO) in Hong Kong, according to an exchange filing. Its stock has lost about 12 per cent since the listing, closing at HK$59.90 on Tuesday.

These moves highlight the trend of Chinese firms going global to provide familiar healthcare options for expatriates.

Relaterede artikler

Venture capitalist Nisa Leung says mainland China and Hong Kong should ease listing rules for biotechnology companies and lower takeover thresholds for listed firms to capitalize on renewed foreign interest in the healthcare sector. She made the comments in a sideline interview during China's annual meetings of the CPPCC and NPC.

Rapporteret af AI

Chinese contract drug makers including WuXi AppTec, WuXi Biologics and WuXi XDC face a less certain long-term revenue outlook as US pharmaceutical companies reshore production amid US-China tensions. Cui Cui, head of healthcare research for Asia at Jefferies, said earnings visibility for 2026 and 2027 remains strong due to order backlogs, but longer-term order growth lacks clarity.

Hong Kong's Financial Services Development Council (FSDC) recommends that the city pitch Southeast Asia and the Middle East for more global listings and issue long-term bonds to attract patient capital. New vice-chairman Rocky Tung Yat-ngok said Indonesia would be the first target market, given its large population and strong mining and Islamic finance sectors.

Rapporteret af AI

China's mainland stock market watchdog is discouraging the establishment of 'red-chip-structured' companies in sensitive industries, dealing a blow to tech and biotech IPO candidates. Industry sources say the move reflects regulators' caution, ensuring asset sales do not escape scrutiny.

Life insurance sales in Hong Kong rose 50.6% to a record US$42.2 billion last year, driven by affluent customers seeking wealth transfer, protection and medical coverage. Paul Murray, CEO of Swiss Re’s life and health business, attributed the growth to more wealthy individuals establishing family offices in the city. Hong Kong’s lack of estate duty and tax incentives for single family offices since 2023 have drawn high-net-worth families.

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis